Cargando…
Unbiased Identification of Dengue Virus Non-Structural Protein 1 Peptides for Use in Vaccine Design
Dengue virus (DENV) is a global health problem, with over half of the world’s population at risk for infection. Despite this, there is only one licensed vaccine available to prevent infection and safety concerns limit immunization to only a subset of individuals. Most dengue virus vaccine efforts at...
Autores principales: | Warner, Nikole L., Core, Susan B., Frietze, Kathryn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784660/ https://www.ncbi.nlm.nih.gov/pubmed/36560438 http://dx.doi.org/10.3390/vaccines10122028 |
Ejemplares similares
-
Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1
por: Warner, Nikole L., et al.
Publicado: (2021) -
Expansion and Refinement of Deep Sequence-Coupled Biopanning Technology for Epitope-Specific Antibody Responses in Human Serum
por: Warner, Nikole L., et al.
Publicado: (2020) -
Epitope-Based Vaccines against the Chlamydia trachomatis Major Outer Membrane Protein Variable Domain 4 Elicit Protection in Mice
por: Collar, Amanda L., et al.
Publicado: (2022) -
Structural Optimization and De Novo Design of Dengue Virus Entry Inhibitory Peptides
por: Costin, Joshua M., et al.
Publicado: (2010) -
Human antibody response to dengue virus: implications for dengue vaccine design
por: Moi, Meng Ling, et al.
Publicado: (2016)